PACS Group, Inc.
NYSE:PACSFinancial - Conglomerates
+$0.41 today
- Market cap
- $7.35B
- Beta
- 0.00
- P/E (TTM)
- 23.0
- EPS (TTM)
- $1.55
Volume 0.78M
Average 0.84M
PACS Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
PACS Group, Inc.NYSE: PACS
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue grows, but more slowly than its trailing trend
Q2 FY2026 cost of revenue of $1.09B rose 6.7% year over year, behind the +11.5% change in trailing-twelve-month cost of revenue. Sequentially, it fell 8.3% from the prior quarter. Over 3 fiscal years it compounded at +26.9% a year.
Context
- Cost of revenue amounted to 78.1% of revenue in FY2025, down 2.5 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +6.7% toward the trailing-twelve-month pace of +11.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 4.13B USD
- Year-over-year change
- +25.3%
- 4-year CAGR
- +43.3%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.13B | +25.3% |
| FY2024 | 2024-12-31 | 3.3B | +23.7% |
| FY2023 | 2023-12-31 | 2.66B | +31.8% |
| FY2022 | 2022-12-31 | 2.02B | +106.4% |
| FY2021 | 2021-12-31 | 979.22M | — |
Cost of Revenue vs competitors
How PACS compares with its peers on the latest reported figures
- PACS's LTM Jun 2026 cost of revenue of $4.46B is the 4th highest of the 11 companies compared; the peer median is $1.8B.
- Its year-over-year change of +11.5% is the 8th highest of 11, against a peer median of +19.9%.
- Cost of revenue amounts to 80.3% of revenue for PACS, versus a peer median of 69.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $55.89B | +30.1% | +6.1% | 71.6% | |
| LTM Mar 2026 | $9.96B | +35.0% | +16.0% | 46.3% | |
| LTM Jun 2026 | $4.71B | +21.3% | +19.3% | 85.9% | |
| LTM Jun 2026 | $4.46B | +11.5% | +26.9% | 80.3% | |
| LTM Jun 2026 | $3.48B | +6.6% | +9.1% | 56.1% | |
| LTM Sep 2026 | $2.52B | +11.2% | +3.6% | 85.5% | |
| LTM Sep 2026 | $1.08B | +16.9% | +10.3% | 68.0% | |
| LTM Jun 2026 | $1.05B | +18.5% | +15.7% | 66.4% | |
| LTM Mar 2026 | $871.95M | +35.1% | +25.8% | 85.2% | |
| LTM Mar 2026 | $749.65M | +9.8% | -21.8% | 79.3% | |
| LTM Mar 2026 | $462.28M | +44.5% | +28.3% | 52.5% | |
| Peer median (excluding PACS) | $1.8B | +19.9% | +13.0% | 69.8% | |
Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 2.42B | 3.11B | 4.09B | 5.29B |
| Cost of Revenue | 979.22M | 2.02B | 2.66B | 3.3B | 4.13B |
| Gross Profit | 187.35M | 400.68M | 447.07M | 792.64M | 1.16B |
| Gross Margin | 16.1% | 16.5% | 14.4% | 19.4% | 21.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 96.83M | 149.01M | 213.66M | 343.81M | 415.07M |
| Operating Expenses | 103.99M | 171.32M | 239.3M | 669.57M | 849.64M |
| Depreciation & Amortization | 7.15M | 22.31M | 25.63M | 40.81M | 55.66M |
| EBITDA | 93.86M | 254.89M | 232.87M | 186.7M | 365.57M |
| EBITDA Margin | 8.0% | 10.5% | 7.5% | 4.6% | 6.9% |
| Operating Income | 83.36M | 229.36M | 207.77M | 123.07M | 309.6M |
| Operating Margin | 7.1% | 9.5% | 6.7% | 3.0% | 5.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.28M | 25.54M | 49.92M | 44.34M | 28.36M |
| Other Income / Expenses | (1.93M) | (22.32M) | (50.46M) | (21.52M) | (25.15M) |
| Income Before Tax | 81.43M | 207.05M | 157.32M | 101.55M | 284.45M |
| Pre-Tax Margin | 7.0% | 8.5% | 5.1% | 2.5% | 5.4% |
| Income Tax Expense | 33.48M | 56.55M | 44.44M | 46.21M | 92.99M |
| Net Income | 47.95M | 150.5M | 112.87M | 55.76M | 191.54M |
| Net Margin | 4.1% | 6.2% | 3.6% | 1.4% | 3.6% |
| EPS (Basic) | 0.32 | 1.00 | 0.75 | 0.38 | 1.23 |
| EPS (Diluted) | 0.32 | 1.00 | 0.75 | 0.38 | 1.22 |
| Weighted Avg Shares | 150.15M | 150.15M | 150.15M | 146.66M | 156.18M |
| Weighted Avg Shares (Diluted) | 150.15M | 150.15M | 150.15M | 148.57M | 156.7M |
PACS Group, Inc.
NYSE:PACS
Intrinsic Alpha fair value
Locked
Current Price
$46.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.